VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$4.72
+0.23 (+5.12%)
Open$4.50
Previous Close$4.49
Day High$4.90
Day Low$4.50
52W High$9.82
52W Low$3.28
Volume—
Avg Volume50.6K
Market Cap84.35M
P/E Ratio—
EPS$-1.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+103.2% upside
Current
$4.72
$4.72
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.98M | 38.61M | 35.73M |
| Net Income | -30,655,510 | -17,468,633 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -22,680,805 | -13,642,373 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |